Skip to main content
Premium Trial:

Request an Annual Quote

ExonHit Therapeutics, Biacore

Premium
ExonHit Therapeutics this week launched its Human GW SpliceArray, a genome-wide splice variant detection tool that monitors more than 23,000 human genes covering 130,000 expressed transcripts and uses over 6 million probes to help study the human proteome.
 
ExonHit said the chip is built on the Affymetrix platform, and offers researchers the ability to interrogate both exons and splice junctions on a single microarray.
 

 
Biacore, a GE Healthcare company, this week launched its Biacore X100 system for label-free protein interaction analysis. The platform uses surface plasmon resonance imaging to determine binding selectivity, kinetics, and affinity using the firm’s suite of sensor chips.
 
Biacore said the automated Biacore X100 is designed for use in busy, multi-project R&D labs, and can provide users with binding information to facilitate protein functionality research.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.